Bronchiectasis is a heterogeneous condition and may be encountered as a stand-alone pulmonary disease by primary care clinicians and specialists in pulmonary medicine. Bronchiectasis sometimes ...
(A) Coronal chest CT shows bilateral lower lobe pleural-based mild reticular opacities with traction bronchiectasis (arrows). (B) Chest radiograph shows subtle corresponding subpleural opacities in ...
Most often secondary to childhood infection, bronchiectasis is irreversible. But there are steps you can take to improve your patients’ quality of life. Bronchiectasis, which is characterized by ...
Brensocatib, a DPP1 inhibitor, is the first FDA-approved therapy for non-cystic fibrosis bronchiectasis, showing significant clinical and structural benefits. The ASPEN trial demonstrated that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results